New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/22/2026

1. SPCX
2. NVDA
3. ACN
4. USO
5. DFTX
6. GOOGL
7. APGE
8. MU
9. HOOD
10. IBM

Go back to New Publication from ICR and Royal Marsden Researchers Highlights the Importance of Ultra-Sensitive ctDNA Testing for Early-Stage Breast Cancer Recurrence Detection

Personalis (PSNL) PT Lowered to $7 at BTIG

March 3, 2025 1:16 PM EST

BTIG analyst Mark Massaro lowered the price target on Personalis (NASDAQ: PSNL) to $7.00 (from $8.00) while maintaining a Buy rating.

The analyst comments "PSNL turned in a solid and productive 2024, highlighted by advancing data development of its NeXT Personal MRD test and... More